indalo therapeutics logo

Indalo Therapeutics, Inc.

Indalo Therapeutics is a biopharmaceutical company discovering and developing novel integrin antagonists for patients suffering from serious fibrotic diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://indalotherapeutics.com
Founded2014
Disease Focus
Development Stage
STOCK CODENA
Address
4320 Forest Park Avenue, Suite 304, Missouri, 63108
St. Louis
United States
Email
Contact Number
+1 314 932 4032

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/indalo-therapeutics” connections=”true” suffix=””]

In Aug 2017, Indalo Therapeutics Raised $9Mn funding in Equity round from various investors which included  BioGenerator, Missouri Technology Corporation, iSelect Fund, and other investors. The utilisation of the funds remain undisclosed.